Two approaches to AI in preclinical drug discovery are diverging, from multi-thousand GPU systems to models with only a ...

ByteDance's drug unit showed an AI-designed IL-17 inhibitor at a Boston conference. The molecule targets interactions pharma called undruggable. Only trials will tell.

The Chan Zuckerberg Initiative announced a $500 million investment in a new research initiative called the Virtual Biology ...

AlphaFold can predict these structures without running experiments. In July 2021, researchers gained access to hundreds of thousands of these AI-predicted structures virtually overnight. Yet, to date, ...

AGI may be achieved by 2030, transforming AI development with groundbreaking advancements and increased productivity.

Recent advances in AI, from AlphaFold to generative models, are reshaping protein design, enabling scientists to create novel proteins with precise functions. Researchers are now developing proteins ...

Using bright X-rays from the Department of Energy's SLAC National Accelerator Laboratory and Lawrence Berkeley National ...

Intrinsically disordered proteins have no single structure, making them challenging for traditional structural biology ...

10x Science, a biotech startup founded in late 2025, has raised $4.8 million in seed funding to accelerate the characterization of AI-generated drug candidates. Its platform merges deterministic ...